October 10th, 2012
Barrett esophagus with high-grade dysplasia: How should it be staged?
I am amazed at the variation I have seen in the use of endoscopic ultrasound (EUS) in staging Barrett esophagus (BE). Some of us use EUS universally, and others (myself included) never use it to stage intramucosal carcinoma or high-grade dysplasia.
So, let me propose a case and ask what you would do: The patient is a healthy 58-year-old man with 3 cm of BE with a 0.5 cm nodule in the distal segment. There is no ulceration or other surface irregularity found upon inspection with high-definition white-light and narrow-band imaging.
Would you:
1) Stage with EUS and resect the nodule?
2) Resect the nodule and stage with EUS only if intramucosal carcinoma or greater neoplasia is seen?
3) Resect the nodule and stage with EUS for invasive adenocarcinoma only?
4) Perform radiofrequency ablation (RFA) of the nodule after staging EUS?
5) Perform RFA of the nodule without staging EUS?
I look forward to your comments.
Categories: Endoscopy, Patient care, Uncategorized
Tags: Barrett esophagus
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
8 Responses to “Barrett esophagus with high-grade dysplasia: How should it be staged?”
M. Brian Fennerty, MD
Founding Editor
NEJM Journal Watch Gastroenterology
Learn more about Gut Check on Gastroenterology.
Pages
Archives
- October 2014
- August 2014
- July 2014
- June 2014
- March 2014
- January 2014
- December 2013
- November 2013
- September 2013
- August 2013
- July 2013
- June 2013
- April 2013
- February 2013
- December 2012
- November 2012
- October 2012
- August 2012
- July 2012
- April 2012
- February 2012
- January 2012
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- October 2010
- August 2010
- July 2010
- March 2010
- February 2010
- January 2010
- December 2009
- July 2009
- June 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
Categories
- Barrett esophagus (1)
- cancer surveillance (4)
- colonoscopy (4)
- drugs (1)
- Endoscopy (23)
- eosinophilic esophagitis (1)
- gastric acid suppression (1)
- Health policy (3)
- Hepatology (3)
- Medical education (1)
- pathology (1)
- Patient care (28)
- polypectomy (2)
- practice environment (3)
- Probiotic therapy (1)
- Ulcer (1)
- Uncategorized (30)
-
Tag Cloud
- Ambulatory endoscopy center antiretroviral therapy Barrett esophagus boceprevir bowel preparation CMS colitis colonoscopy colorectal cancer screening CT colonography DDW drug interactions efavirenz endoscopist Endoscopy gastroenterology GI bleeding hepatitis HIV IBS Irritable Bowel Syndrome Medicare midazolam nurse Plavix PPIs primary care probiotics ritonavir Screening colonoscopy sedation sigmoidoscopy telaprevir training virtual colonoscopy
I perform EUS and would feel much safer staging with EUS first then performing EMR.
perfom RF abalation of nodule after EUS
I WILL RESECT THE NODULE AND STAGE WITH EUS ONLY IF INTRAMUCOSAL CARCINOMA OR GREATER NEOPLASIA IS SEEN
Option 3
Resect with EMR, and then only EUS if you are staging an invasive cancer. EUS often over- or under-stages mucosal lesions.
Dear Dr. Fennerty,
we perform EUS prior to resection only if a higher degree of invasive carcinoma is suspected. If not, I would rather go ahead with your second option to resect the nodule endoscopically and apply EUS later on only if a submucosal carcinoma or greater neoplasia is seen.
Best regards.
Stephan
Resect the nodule and stage with EUS only if intramucosal carcinoma or greater neoplasia is seen
I had exactly the patient you described 1 yea ago.
patient with barret’s of 2-3 cm. that was on surveillance for years. a nodule of 0,5 cm. appeared that was adenocarcinoma: I send him for EUS–> resection of the nodule–> and RFA OF THE BARRETT’S. until now he is o’kay. his age about 60 and very fat: high operation risk.